SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul A who wrote (106)12/9/1998 7:56:00 PM
From: Bo Didley  Read Replies (3) of 1084
 
"ASTOUNDING LIFESAVING TECHNOLOGY"
per NBC

They did a report on a little girl who had the technology
used on her to cure CANCER.

No one had to go through a painful bone marrow harvesting
to acquire stem cells. Plus they don't have to find a
blood match cause stem cells are generic. Finding a match
by the old way-- rejection is a problem. No problemo for ASTM.
ASTM technology has no autoimmune rejection ! ! ! ! ! !

ASTM's technology was used. IT SAVES LIVES. No mention of the company's name, but it gave a lead for curious people to start searching...like they had to search for GERN, when it's name was not mentioned. GERN ended up gapping from $10 to $23.

ASTM is going to the CANCER CONFERANCE this WEEK !
They will be the "hot stock" everyone is talking about,
along with the innovative technology for stem cells.

Cancer Conferance begins Dec. 12.

It will obviously gap. What will keep it going are the
other news coverage it will get by newspapers.
It has NEWS APPEAL. It also has the "unknown" factor
of what will happen at the Cancer Conferance. People
will buy it for that unknown Positive factor.

bo


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext